THERAPEUTIC HUMAN MAST CELLS, COMPOSITIONS, AND METHODS OF TREATING A TUMOR COMPRISING ADMINISTERING AUTOLOGOUS HUMAN MAST CELLS FROM ADIPOSE TISSUE
This disclosure is directed to mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; compositions comprising mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; and met...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
03.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure is directed to mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; compositions comprising mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; and methods of treating a tumor in a subject, comprising administering to a subject a therapeutically effective amount of mast cells obtained from adipose derived stem cells, wherein the mast cells are autologous to the subject and sensitized with immunoglobulin-E targeted to a cancer antigen.
La présente invention concerne des mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux et sensibilisés avec l'immunoglobuline E ciblée vers un antigène du cancer; des compositions comprenant des mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux et sensibilisées avec l'immunoglobuline E ciblée vers un antigène du cancer; et des procédés de traitement d'une tumeur chez un sujet, comprenant l'administration à un sujet d'une quantité thérapeutiquement efficace de mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux, les mastocytes étant autologues pour le sujet et sensibilisés avec l'immunoglobuline E ciblée vers un antigène du cancer. |
---|---|
Bibliography: | Application Number: WO2018US40183 |